Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice

It is judged safe to discontinue treatment with tyrosine kinase inhibitors (TKI) for chronic myeloid leukemia (CML) in experimental trials on treatment-free remission (TFR). We collected a total of 293 Italian patients with chronic phase CML who discontinued TKI in deep molecular response. Seventy-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Fava, Carmen, Rege-Cambrin, Giovanna, Dogliotti, Irene, Cerrano, Marco, Berchialla, Paola, Dragani, Matteo, Rosti, Gianantonio, Castagnetti, Fausto, Gugliotta, Gabriele, Martino, Bruno, Gambacorti-Passerini, Carlo, Abruzzese, Elisabetta, Elena, Chiara, Pregno, Patrizia, Gozzini, Antonella, Capodanno, Isabella, Bergamaschi, Micaela, Crugnola, Monica, Bocchia, Monica, Galimberti, Sara, Rapezzi, Davide, Iurlo, Alessandra, Cattaneo, Daniele, Latagliata, Roberto, Breccia, Massimo, Cedrone, Michele, Santoro, Marco, Annunziata, Mario, Levato, Luciano, Stagno, Fabio, Cavazzini, Francesco, Sgherza, Nicola, Giai, Valentina, Luciano, Luigia, Russo, Sabina, Musto, Pellegrino, Caocci, Giovanni, Sorà, Federica, Iuliano, Francesco, Lunghi, Francesca, Specchia, Giorgina, Pane, Fabrizio, Ferrero, Dario, Baccarani, Michele, Saglio, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669161/
https://www.ncbi.nlm.nih.gov/pubmed/30819917
http://dx.doi.org/10.3324/haematol.2018.205054

Ejemplares similares

Ejemplares similares